Atlanta startups have disclosed at least $670 million in new venture funding through May 17, 2026, anchored by Hermeus’ $350 million Series C in April and Flock Safety’s $200 million-plus secondary share authorization at an $8.4 billion valuation. The pace puts metro Atlanta on track to clear $1.5 billion in 2026, roughly double the city’s $756.5 million total for all of 2025. Two of the largest rounds — Hermeus and Altesa BioSciences — were led by out-of-region investors (Khosla Ventures and Forbion, respectively), confirming a thesis Atlanta’s ecosystem has spent five years chasing: that national venture capital is now writing eight- and nine-figure checks into Georgia-headquartered companies without requiring them to relocate first.
Methodology
This tracker covers every disclosed funding event involving an Atlanta-area company between January 1, 2026 and May 17, 2026, sourced from Hypepotamus, Atlanta Business Chronicle, Crunchbase, Bloomberg, TechCrunch, BioPharma Dive, AJC, BusinessWire, and PR Newswire. “Atlanta-based” is defined as HQ in metro Atlanta (Fulton, DeKalb, Cobb, Gwinnett, Clayton, Cherokee, Forsyth counties) or founded in Atlanta with a continuing operational presence. Rounds include priced equity rounds (Series A through C), notable seed rounds above $3 million, and material secondary share authorizations. Hermeus is included despite its April 2026 announcement that it is relocating headquarters to El Segundo, California — the company was Atlanta-founded, retains its Atlanta production facility, and the round closed prior to the move. Numbers represent disclosed totals only; undisclosed rounds and corporate venture investments without public dollar figures are excluded.
The Tracker: Every Disclosed Atlanta Round, 2026 YTD
| Company | Stage | Amount | Date | Lead Investor | Sector | Founder/CEO |
|---|---|---|---|---|---|---|
| Hermeus | Series C | $350M ($200M equity + $150M debt) | April 7, 2026 | Khosla Ventures | Defense / Hypersonic Aerospace | AJ Piplica |
| Flock Safety | Secondary / Share Authorization | ~$200M at $8.4B valuation | April 2026 | Andreessen Horowitz (existing) | Public Safety AI | Garrett Langley |
| Altesa BioSciences | Series B | $75M | February 19, 2026 | Forbion | Biotech / Respiratory | Brett Giroir, MD |
| Zamp | Seed / Series A | $30M total ($17M new) | April 28, 2026 | Acrew Capital | Fintech / Tax Compliance | Rohit Bhadange |
| Zero RFI | Seed | $13.8M | March 16, 2026 | General Catalyst | Construction AI | KP Reddy |
| Fulfillment IQ | Venture | $10.2M | January 2026 | Undisclosed | Supply Chain SaaS | Sanjay Gupta, Ninaad Acharya |
| Askari Defense | Seed | Undisclosed (out-of-stealth) | April 7, 2026 | Overline VC | Defense / Drone Interceptors | Marc van Zyl (CTO) |
| Sanguina | Strategic | Undisclosed (syndicate) | April 2026 | EBFI / Invest Georgia / GT Research Impact Fund | Healthtech / Diagnostics | Erika Tyburski |
| Pull Logic | Seed | $3.3M | January 2026 | New Build Venture Capital | Supply Chain AI | Sundar Subramanian |
Combined disclosed total: ~$682 million across nine confirmed rounds, with two additional rounds (Askari Defense, Sanguina) excluded from the dollar total because amounts were not disclosed. The Hermeus and Flock Safety rounds alone account for approximately 80% of the disclosed capital.
Biggest Rounds of 2026 So Far
Hermeus — $350M Series C (April 2026)
Hermeus closed the largest priced equity round announced by any Atlanta-founded company in 2026 and converted into a unicorn in the same breath. The hypersonic aircraft startup raised $200 million in equity led by Khosla Ventures, with participation from Canaan Partners, Founders Fund, RTX Ventures, Bling Capital, In-Q-Tel, Cox Enterprises’ Socium Ventures, Georgia Tech Foundation, Destiny Tech100, 137 Ventures, and GSBackers. A further $150 million in debt came from Silicon Valley Bank, Pinegrove Venture Partners, Hercules Capital, and Trinity Capital. The round followed the March 2026 successful test of the Quarterhorse Mk 2.1 at White Sands Missile Range.
The complicating footnote: Hermeus announced alongside the round that it is moving its headquarters from Atlanta to El Segundo, California — although the company will keep its Atlanta facility operational as a production site with no Atlanta layoffs planned. For more on what Atlanta’s expanding unicorn roster looks like in 2026, see our companion piece.
Flock Safety — $200M+ Share Authorization at $8.4B (April 2026)
Flock Safety’s April 2026 round was structurally a secondary share authorization rather than a traditional primary equity raise, but it functioned as the largest valuation event of the year for any Atlanta company. Per reporting from The Information, Flock authorized roughly $200 million in new shares at an $8.4 billion valuation — up from $7.5 billion in March 2025 — as the AI-powered license plate reader company simultaneously navigates record revenue growth and a national debate over surveillance. The company now operates at $300 million-plus in annual recurring revenue and has raised approximately $1 billion in total funding, anchored by Andreessen Horowitz. Read our deep-dive on Garrett Langley and Flock Safety for the full operational picture.
Altesa BioSciences — $75M Series B (February 2026)
Altesa BioSciences closed an oversubscribed $75 million Series B on February 19, 2026, led by Dutch life-sciences firm Forbion with participation from Sanofi and existing investors Medicxi, Pitango, and Atlantic Partners. The clinical-stage Atlanta biotech is developing vapendavir, a first-in-class oral antiviral targeting rhinovirus — the predominant trigger of respiratory exacerbations in patients with COPD and asthma.
Proceeds will fund the Phase 2b CARDINAL study enrolling 900 COPD patients across the US and UK beginning Q2 2026. Altesa is led by Dr. Brett Giroir, former US Assistant Secretary for Health under the first Trump administration, with Dr. Katharine Knobil (former GSK CMO) as Chief Medical Officer.
Zero RFI — $13.8M Seed (March 2026)
Construction-AI platform Zero RFI launched out of stealth on March 16, 2026 with a $13.8 million seed round led by General Catalyst. Founded by serial Atlanta technologist KP Reddy, the company simultaneously announced acquisitions of Brookwood Group, BuildingWorks, and KP Reddy Co. — an unusual “launch + roll-up” structure. Reddy is dual-coastal (Atlanta and San Francisco); the company is operating out of both markets.
“Atlanta’s 2026 funding pattern is what a maturing ecosystem looks like, not a hype cycle. National lead investors are writing the big checks — Khosla into Hermeus, Forbion into Altesa, General Catalyst into Zero RFI — but the rounds are syndicated locally. Georgia Tech Foundation took allocation in Hermeus’ Series C. Tech Square Ventures stays in every Rainforest round. That’s the signal — Atlanta is no longer a feeder market.”
— Eshan Ravuri, CEO, Angry Digital Inc.
Where the Money Is Going: 2026 Sector Breakdown
The dollar distribution of Atlanta’s 2026 disclosed capital is heavily concentrated in two sectors: defense/aerospace and biotech, driven by the Hermeus and Altesa rounds. Public safety AI follows close behind via Flock Safety. Below is the share of disclosed 2026 capital by sector:
| Sector | Disclosed Capital (YTD) | Share of Total | Leading Round |
|---|---|---|---|
| Defense / Aerospace | $350M | 51% | Hermeus ($350M) |
| Public Safety AI | $200M+ | 29% | Flock Safety (~$200M) |
| Biotech / Healthtech | $75M+ | 11% | Altesa BioSciences ($75M) |
| Fintech / Compliance | $30M | 4% | Zamp ($30M total) |
| Construction AI | $13.8M | 2% | Zero RFI ($13.8M) |
| Supply Chain SaaS | $13.5M | 2% | Fulfillment IQ ($10.2M) + Pull Logic ($3.3M) |
| Defense / Drones | Undisclosed | — | Askari Defense |
The sector composition marks a notable shift from 2025, when fintech and supply chain dominated Atlanta’s funding mix. Defense tech in particular is new: Hermeus and Askari Defense are both 2024-founded companies that hit material funding milestones in the same April 2026 window, reflecting a broader national thesis on US defense industrial base reshoring.
Consumer and DTC are absent from the 2026 priced-round tracker so far — although several Atlanta DTC brands have continued to scale revenue without new outside capital. See our breakdown of Atlanta Shopify DTC brands in 2026 for that story.
Who’s Investing in Atlanta in 2026
Lead investors in 2026 Atlanta rounds skew national, with select Atlanta-based firms taking allocation as syndicate participants. The most active investors in disclosed 2026 Atlanta rounds, by round count and round size:
| Investor | HQ | 2026 Atlanta Rounds | Largest Position |
|---|---|---|---|
| Khosla Ventures | Menlo Park, CA | 1 | Hermeus Series C (lead) |
| Andreessen Horowitz | Menlo Park, CA | 1 (existing) | Flock Safety |
| Forbion | Naarden, Netherlands | 1 | Altesa Series B (lead) |
| General Catalyst | Cambridge, MA | 1 | Zero RFI Seed (lead) |
| Acrew Capital | San Francisco, CA | 1 | Zamp (lead) |
| Overline VC | Atlanta | 1 | Askari Defense (lead) |
| Georgia Tech Foundation | Atlanta | 1 | Hermeus Series C (participant) |
| Cox Enterprises (Socium Ventures) | Atlanta | 1 | Hermeus Series C (participant) |
| Tech Square Ventures | Atlanta | Multiple (incl. existing positions) | Rainforest (existing) |
| New Build Venture Capital | TX | 1 | Pull Logic Seed (lead) |
Atlanta’s home-team investors — Overline VC, Tech Square Ventures, BIP Capital, Panoramic Ventures, TTV Capital — continue to lead at the seed and Series A stages but are increasingly co-investing rather than leading at Series B+. That mirrors the national pattern in secondary venture markets: local capital builds the pipeline; coastal and European capital scales the breakouts.
How Atlanta Compares: 2026 vs 2025 and Peer Markets
Atlanta’s 2026 first-half pace is a sharp acceleration on 2025. The 2025 full-year disclosed total was $756.5 million across all stages (a figure that grew 23% year-over-year). At $670 million-plus in just the first 4.5 months of 2026, Atlanta is on pace for roughly $1.5–$1.8 billion in calendar 2026 — roughly 2× the 2025 total — if current deal velocity holds.
A direct comparison to Atlanta’s Sun Belt peers as of May 2026 YTD:
| Market | 2026 YTD Disclosed Venture | 2025 Full-Year | YoY Pace |
|---|---|---|---|
| Atlanta | ~$682M | $756.5M | +136% (annualized) |
| Austin | ~$2.1B | $4.8B | +13% (annualized) |
| Miami | ~$1.4B | $3.1B | +8% (annualized) |
| Nashville | ~$310M | $542M | +37% (annualized) |
| Charlotte | ~$215M | $487M | +6% (annualized) |
Atlanta is the fastest-accelerating market in the Sun Belt cohort in 2026 YTD, although Austin and Miami remain materially larger by absolute dollars. The acceleration is driven by mega-rounds (Hermeus, Flock Safety) rather than deal count — a pattern that is fragile if even one large round slips to 2027.
“Founders should read this funding pattern carefully. Two mega-rounds inflate the topline, but the seed-to-Series A bridge is where most Atlanta companies actually live. Zero RFI raised $13.8M at seed because General Catalyst was willing to underwrite the roll-up thesis on day one. Most founders won’t have that. Plan runway like 2026’s mega-round backdrop doesn’t apply to you — because it probably doesn’t.”
— Terrence Phillip, COO, Angry Digital Inc.
What’s Next: Companies Rumored to Be Raising
Several Atlanta companies are reportedly in market in Q2–Q3 2026, based on industry reporting and investor briefings:
- Sanguina — Following the April 2026 strategic syndicate investment, the at-home anemia diagnostics company is expected to open a formal Series A in late 2026.
- The Elephant Room — Atlanta music-tech startup that completed Techstars Emory in early 2026; pre-seed round opening.
- Stord — Atlanta supply-chain unicorn; previously raised at a $1.3B valuation, periodically reported to be evaluating growth-equity options.
- Greenlight — Family fintech unicorn; secondary activity reported but no announced primary round.
Sectors heating up: defense tech (following the Hermeus and Askari signals), AI-native vertical SaaS (Zero RFI’s construction play), and respiratory biotech (Altesa’s data readouts from CARDINAL will determine whether the sector continues to attract national capital).
The honest caveat: rumored rounds slip. Hermeus’ $350M was rumored for nine months before it closed. Treat this section as directional, not as a calendar.
Frequently Asked Questions
How much funding have Atlanta startups raised in 2026?
Atlanta startups have disclosed at least $682 million in new venture funding between January 1, 2026 and May 17, 2026, across nine confirmed rounds. The figure is concentrated in two mega-rounds: Hermeus’ $350 million Series C in April and Flock Safety’s ~$200 million share authorization at an $8.4 billion valuation. Combined, those two events represent approximately 80% of disclosed 2026 capital.
Which Atlanta startups raised Series A in 2026?
The clearest Atlanta-area Series-stage rounds in 2026 to date are Altesa BioSciences ($75M Series B, February), Hermeus ($350M Series C, April), and Zamp ($30M total at the seed/Series A boundary, April). Zero RFI’s $13.8M seed round in March was led by General Catalyst and is structured more like a Series A in scale. True Series A rounds at the traditional $9–12M Atlanta median have been quieter through early 2026 compared to the breakout later-stage activity.
What is the biggest Atlanta startup funding round in 2026?
Hermeus’ $350 million Series C, announced April 7, 2026, is the largest priced equity round of the year for any Atlanta-founded company. The round was led by Khosla Ventures and minted Hermeus as Atlanta’s newest unicorn at a $1 billion-plus valuation. Flock Safety’s $200 million-plus secondary share authorization at an $8.4 billion valuation in April 2026 is the largest valuation event of the year but is structurally a secondary transaction.
How does Atlanta startup funding compare to 2025?
Atlanta’s 2026 first-half pace is roughly 90% of 2025’s full-year disclosed total of $756.5 million — meaning Atlanta is on track to roughly double 2025’s funding in calendar 2026 if current deal velocity holds. The acceleration is driven by two mega-rounds (Hermeus, Flock Safety) rather than higher overall deal count. 2025 itself grew 23% year-over-year over 2024, so the trend line is two consecutive years of meaningful acceleration.
Who are the top venture capital investors in Atlanta in 2026?
The largest 2026 Atlanta rounds were led by national and international firms: Khosla Ventures (Hermeus), Forbion (Altesa BioSciences), General Catalyst (Zero RFI), Acrew Capital (Zamp), and Andreessen Horowitz (Flock Safety, existing). Atlanta-based lead investors include Overline VC (Askari Defense), Tech Square Ventures, BIP Capital, Panoramic Ventures, and TTV Capital, who are increasingly serving as syndicate participants rather than lead investors at Series B and later.
